文献速递牙体牙髓病

微小RNA-22通过靶向HIF-1α和NLRP3抑制人牙髓成纤维细胞中NLRP3/CASP1炎症小体通路介导的促炎细胞因子产生

MicroRNA-22 suppresses NLRP3/CASP1 inflammasome pathway-mediated proinflammatory cytokine production by targeting the HIF-1α and NLRP3 in human dental pulp fibroblasts.
PubMed 文献 · Int Endod J · 2022-08-25

本研究探讨miR-22对HIF-1α和NLRP3的协同调控及其对NLRP3/CASP1炎症小体通路介导的IL-1β和IL-18分泌的影响。在牙髓炎进展中,miR-22表达下降而HIF-1α和NLRP3表达升高;荧光素酶报告实验证实NLRP3和HIF-1α均为miR-22的直接靶点。miR-22模拟物抑制而抑制剂促进ATP加LPS及缺氧诱导的炎症小体通路激活,提示miR-22-HIF-1α-NLRP3信号可能成为牙髓治疗的潜在靶点。

要点

  • 可逆性牙髓炎向不可逆性牙髓炎转化时,人牙髓组织中miR-22表达下降而HIF-1α和NLRP3表达升高(p < .05)。
  • NLRP3和HIF-1α均为miR-22在人牙髓成纤维细胞中的直接靶点。
  • miR-22模拟物显著抑制ATP加LPS及缺氧诱导的NLRP3/CASP1炎症小体通路激活(p < .05)。

核心结论

  • MiR-22作为协同负调控因子,通过靶向NLRP3和HIF-1α参与控制NLRP3/CASP1炎症小体通路介导的促炎细胞因子分泌。
  • 研究结果揭示了miR-22-HIF-1α-NLRP3信号在控制促炎细胞因子分泌中的新功能与机制。
  • 研究提示该信号通路可能成为未来牙髓治疗的潜在治疗策略。

研究设计与样本

  • 本研究为体外细胞实验,使用人牙髓成纤维细胞和人牙髓组织。
  • 通过荧光原位杂交和免疫荧光确定miR-22-3p、NLRP3和HIF-1α在人牙髓组织中的定位。
  • 使用miR-22模拟物、抑制剂或NLRP3/HIF-1α质粒分别上调和下调人牙髓成纤维细胞中miR-22、NLRP3或HIF-1α的表达。
  • 通过TargetScan 5.1计算预测和荧光素酶报告实验确认靶点关联。
  • 采用qRT-PCR和蛋白质印迹法检测mRNA和蛋白表达,ELISA分析IL-1β和IL-18释放,单因素方差分析比较组间差异,p < .05为差异有统计学意义。

主要发现

  • 与健康牙髓组织相比,可逆性牙髓炎向不可逆性牙髓炎转化过程中人牙髓组织中miR-22表达下降而HIF-1α和NLRP3表达升高(p < .05)。
  • 正常牙髓组织中miR-22-3p广泛表达于牙髓细胞,HIF-1α和NLRP3主要表达于成牙本质细胞和血管内皮细胞;炎症牙髓组织中成牙本质细胞层被破坏。
  • 人牙髓成纤维细胞对miR-22-3p、HIF-1α和NLRP3均呈阳性。
  • TargetScan 5.1计算预测和荧光素酶报告实验证实NLRP3和HIF-1α均为miR-22在人牙髓成纤维细胞中的直接靶点。
  • miR-22抑制剂进一步促进ATP加LPS及缺氧诱导的NLRP3/CASP1炎症小体通路激活(p < .05),而miR-22模拟物显著抑制该激活(p < .05)。

关键数值与推荐

  • 可逆性牙髓炎向不可逆性牙髓炎转化时人牙髓组织中miR-22表达下降而HIF-1α和NLRP3表达升高,与健康牙髓组织比较p < .05。
  • miR-22抑制剂促进ATP加LPS及缺氧诱导的NLRP3/CASP1炎症小体通路激活,p < .05。
  • miR-22模拟物抑制ATP加LPS及缺氧诱导的NLRP3/CASP1炎症小体通路激活,p < .05。

临床怎么用

  • 原文结论提示miR-22-HIF-1α-NLRP3信号通路可能成为未来牙髓治疗的潜在治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To investigate the synergetic regulatory effect of miR-22 on HIF-1α and NLRP3, subsequently regulating the production of the NLRP3/CASP1 inflammasome pathway-mediated proinflammatory cytokines IL-1β and IL-18 in human dental pulp fibroblasts (HDPFs) during the progression of pulpitis. METHODOLOGY: Fluorescence in situ hybridization (FISH) and immunofluorescence (IF) were performed to determine the localization of miR-22-3p, NLRP3 and HIF-1α in human dental pulp tissues (HDPTs). The miR-22 mimics and inhibitor or plasmid of NLRP3 or HIF-1α were used to upregulate or downregulate miR-22 or NLRP3 or HIF-1α in HDPFs, respectively. Computational prediction via TargetScan 5.1 and a luciferase reporter assay were conducted to confirm target association. The mRNA and protein expression of HIF-1α, NLRP3, caspase-1, IL-1β and IL-18 were determined by qRT-PCR and western blotting, respectively. The release of IL-1β and IL-18 was analysed by ELISA. The significance of the differences between the experimental and control groups was determined by one-way analysis of variance, p < .05 indicated statistical significance. RESULTS: A decrease in miR-22 and an increase in HIF-1α and NLRP3 in HDPTs occurred during the transformation of reversible pulpitis into irreversible pulpitis compared with that in the healthy pulp tissues (p < .05). In the normal HDPTs, miR-22-3p was extensively expressed in dental pulp cells. HIF-1α and NLRP3 were mainly expressed in the odontoblasts and vascular endothelial cells. Whereas in the inflamed HDPTs, the odontoblast layers were disrupted. HDPFs were positive for miR-22-3p, HIF-1α and NLRP3. Computational prediction via TargetScan 5.1 and luciferase reporter assays confirmed that both NLRP3 and HIF-1α were direct targets of miR-22 in HDPFs. The miR-22 inhibitor further promoted the activation of NLRP3/CASP1 inflammasome pathway induced by ATP plus LPS and hypoxia (p < .05). In contrast, the miR-22 mimic significantly inhibited the NLRP3/CASP1 inflammasome pathway activation induced by ATP plus LPS and hypoxia (p < .05). CONCLUSION: MiR-22, as a synergetic negative regulator, is involved in controlling the secretion of proinflammatory cytokines mediated by the NLRP3/CASP1 inflammasome pathway by targeting NLRP3 and HIF-1α. These results provide a novel function and mechanism of miR-22-HIF-1α-NLRP3 signalling in the control of proinflammatory cytokine secretion, thus indicating a potential therapeutic strategy for future endodontic treatment.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Jiang W, Sun S, Wang D, et al. MicroRNA-22 suppresses NLRP3/CASP1 inflammasome pathway-mediated proinflammatory cytokine production by targeting the HIF-1α and NLRP3 in human dental pulp fibroblasts. Int Endod J. 2022. PMID: 35979583. doi:10.1111/iej.13814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。